Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 01, 2024 10:05 ET | Source: Research and Markets

Global Iron Deficiency Anemia Therapy Market Poised for Growth, Forecasted to Reach $4.6 Billion by 2030

Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Iron Deficiency Anemia Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
January 24, 2024 14:20 ET | Source: Research and Markets

Global Iron Deficiency Anemia Therapy Market Analysis 2024-2034 Featuring Profiles of Leading Players Including AbbVie, Bayer, CSL Vifor, Sanofi, and Teoxane

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Iron Deficiency Anemia Therapy Market Analysis & Forecast 2024-2034" report has been added to ResearchAndMarkets.com's offering. The...
March 24, 2022 05:08 ET | Source: Research and Markets

Fanconi Anemia Market Research Report 2022: Insight, Epidemiology and Market Forecasts 2019-2032 with Focus on United States, Germany, Spain, Italy, France, United Kingdom and Japan

Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Fanconi Anemia - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering. This "Fanconi...
March 04, 2022 07:43 ET | Source: Research and Markets

Iron Deficiency Anemia Market Research Report 2022

Dublin, March 04, 2022 (GLOBE NEWSWIRE) -- The "Iron Deficiency Anemia - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering. The Iron...
March 19, 2021 07:28 ET | Source: Research and Markets

Global Chronic Kidney Disease Anemia Drug Forecast and Market Analysis Report 2021-2029 - New Pipeline Products Will Help in Partially Addressing Some Unmet Needs

Dublin, March 19, 2021 (GLOBE NEWSWIRE) -- The "Chronic Kidney Disease Anemia - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. The...